COREGUILD THERAPY

Serial Number 99209942
681

Registration Progress

Application Filed
May 30, 2025
Under Examination
Approved for Publication
Published for Opposition
Nov 18, 2025
Registered

Trademark Image

COREGUILD THERAPY

Basic Information

Serial Number
99209942
Filing Date
May 30, 2025
Published for Opposition
November 18, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
681
Status Date
Oct 29, 2025
Application
Pending
Classes
005 040 042 044

Rights Holder

Notitia Biotechnologies Company

03
Address
11 Deerpark Drive, Suite 100
Monmouth Junction, NJ 08852

Ownership History

Notitia Biotechnologies Company

Original Applicant
03
Monmouth Junction, NJ

Legal Representation

Attorney
Dana S. Gross

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

9 events
Date Code Type Description Documents
Oct 21, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 21, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 21, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 21, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Oct 21, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 17, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 6, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 30, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 30, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Nutritional supplements; Cultures of microorganisms for medical use; Preparations of microorganisms for medical purposes; Diagnostic agents for pharmaceutical purposes; Biologics in the nature of pharmaceutical preparations for the treatment of diseases induced by a dysbiotic gut microbiota and inflammation
Class 040
Custom biomanufacturing of pharmaceuticals
Class 042
Cell culture services for scientific and research purposes, for others; Culturing of cells for others for biomanufacturing; Laboratory services for biomanufacturing; Laboratory services for the production of pharmaceuticals in the nature of culturing of cells for others
Class 044
Medical testing services; Cultured cell bank services for medical transplantation

Additional Information

Pseudo Mark
CORE GUILD THERAPY

Classification

International Classes
005 040 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPY"